Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

112.80 -0.20 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corp

< Previous 1 2 3 4 5 6 7 Next >
Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban?
The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report
Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,... 
Via Benzinga
Topics ETFs
Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know
Via Benzinga
Robinhood, eBay, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Recap: Masimo Q3 Earnings
Via Benzinga
What 7 Analyst Ratings Have To Say About Masimo
Via Benzinga
Big Tech Earnings, Results From a Couple of Financial Companies, and a Look at Spotify
We also chat with author Michael Lewis about Sam Bankman-Fried. 
Via The Motley Fool
Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI)  
Via Benzinga
Masimo Surges After Winning A Potential $100 Million Battle Against Apple
Federal officials say Apple violated patent laws in its Apple Watch. 
Via Investor's Business Daily
Topics Intellectual Property
Exposures Intellectual Property
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge
As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Shares of Masimo Are Dropping Tuesday
The company's preliminary second-quarter numbers have investors worried. 
Via The Motley Fool
Apple's Timepiece Trouble: Patent Dispute Puts Apple Watch Imports in Jeopardy
The U.S. International Trade Commission may ban the import of Apple Watches due to a patent infringement dispute with medical tech firm Masimo, pending a presidential review and potential appeals. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Disney's Lost Decade and Next Act
The market's had a surprisingly strong 2023, but investors might be eying easy low-risk yields elsewhere. 
Via The Motley Fool
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
Via Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77.... 
Via Benzinga
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also... 
Via Benzinga
Masimo Plummets To Five-Year Low On Light Sales, 'Longer-Term' Challenges Persist
The company works primarily in health care, but its non-health care efforts are floundering. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Via Benzinga
CMG Stock Alert: Chipotle Announces International Expansion Plan
Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. 
Via InvestorPlace
Why Is Masimo (MASI) Stock Down 30% Today?
Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023. 
Via InvestorPlace
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... 
Via Benzinga
Masimo Analysts Cut Their Forecasts Following Preliminary Q2 Results
Masimo Corporation (NASDAQ: MASI) reported weak preliminary revenue results for the second quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.